2021 American Transplant Congress
Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR)
*Purpose: There is currently no FDA approved immunosuppressive regimen for lung transplant (Tx) recipients; however, patients routinely receive a calcineurin inhibitor-based regimen. The SRTR database…2021 American Transplant Congress
Nurse and Nurse Practitioner-lead Monoclonal Antibody Initiative for Solid Organ Transplant (sot) Recipients with Covid-19
1Johns Hopkins Comprehensive Transplant Center, Baltimore, MD, 2Johns Hopkins, Baltimore, MD
*Purpose: Monoclonal antibody (mAB) infusion (bamlanivimab or casirivimab/imdevimab) for symptomatic, non-hypoxemic, high-risk outpatients with COVID-19 infection, is an available early intervention for COVID-19+ SOT recipients.…2021 American Transplant Congress
Pre-Procurement Cardiac Arrest in Lung Allograft Donors and Effects on Recipient Outcomes
Indiana University School of Medicine, Indianapolis, IN
*Purpose: This study seeks to help expand the lung transplant donor pool by demonstrating the safe use of lung allografts from donors who underwent pre-procurement…2021 American Transplant Congress
Incidence and Risk Factors for Nonmelanoma Skin Cancer in Lung Transplant Recipients
*Purpose: The purpose of this study is to identify the incidence of nonmelanoma skin cancer (NMSC) post lung transplantation and to examine the relationship between…2021 American Transplant Congress
Outcomes After Abo Incompatible Pediatric Liver Transplantation are Comparable to Abo Identical/compatible Transplant
*Purpose: In order to evaluate if the incidence of vascular and biliary complications as well as patient and graft survival in ABO incompatible (ABOi) liver…2021 American Transplant Congress
Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy
*Purpose: To examine our single center experience in the operative management of pediatric liver transplantation (LT) patients with challenging portal vein (PV) anomalies.*Methods: We retrospectively…2021 American Transplant Congress
Peripheral Lymphocyte Profiling and Increased Risk of EBV Infection in Pediatric Liver Transplant Recipients
*Purpose: Epstein-Barr virus “EBV” infection and post-transplant lymphoproliferative disorders “PTLD” are significant comorbidities in the post-transplant “PT” setting, especially in pediatrics. The synergy among T…2021 American Transplant Congress
Therapeutic Enoxaparin Dosing in Lung Transplant Recipients
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Enoxaparin 1 mg/kg subcutaneously every 12 hours for therapeutic anticoagulation is known to increase rates of supratherapeutic anti-Xa levels in lung transplant recipients (LTRs).…2021 American Transplant Congress
Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)
1OPTN DTAC, Richmond, VA, 2UNOS, Richmond, VA
*Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…2021 American Transplant Congress
Deep Learning Based Automatic Liver Volume Estimation and Segmentation via U-net Convolutional Neural Network
1InformAI, Houston, TX, 2Baylor College of Medicine, Houston, TX, 3Houston Methodist, Houston, TX
*Purpose: To create a deep learning model to accurately perform abdominal organ segmentation and volumetric measurements on existing donor and recipient imaging for size matching.*Methods:…
- « Previous Page
- 1
- …
- 221
- 222
- 223
- 224
- 225
- …
- 1683
- Next Page »